The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of Alzheimer's disease globally. The hi ...

JPMorgan upgraded Amneal Pharmaceuticals (AMRX) to Overweight from Neutral with a price target of $12, up from $9. The firm cites the Crexont ...

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's ...

Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for ...

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe ...

The approvals provide therapies for dementia, oncology and gastrointestinal disease. Kroger is cutting about 200 employees across three office sites, and Albertsons is laying off more than 150 ...

One alternative might be memantine, which is usually given with a cholinesterase inhibitor in people with AD as severe as your husband’s. Even by itself, it still might have some benefit in ...